klacid paediatric suspension 125mg/5ml granules for oral suspension
mylan ire healthcare limited - clarithromycin - granules for oral suspension - clarithromycin 125 milligram(s)/5 millilitre - antibacterials for systemic use
klacid 125mg-5ml susp granules for oral suspension
abbvie srl - clarithromycin - granules for oral suspension - 25 mg/ml
klacid 250 mg coated tablets
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - coated tablet - clarithromycin 250 mg - antibacterials for systemic use
klacid paediatric suspension 125mg/5ml, granules f
abbott laboratories ireland ltd - clarithromycin - granules for oral suspension - 125 mg/5ml
klacid 500 mg coated tablets
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - coated tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid xl modified-release tablets 500mg
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - modified-release tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid
viatris limited - clarithromycin 500mg; ; clarithromycin 500mg - film coated tablet - 500 mg - active: clarithromycin 500mg excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow sorbic acid sorbitan oleate stearic acid titanium dioxide vanillin active: clarithromycin 500mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow sorbic acid sorbitan oleate stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.
klacid iv
viatris limited - clarithromycin 500mg; - powder for injection - 500 mg - active: clarithromycin 500mg excipient: lactobionic acid sodium hydroxide - klacid i.v. is indicated whenever parenteral therapy is required for treatment of sensitive microorganisms in the following conditions: · upper respiratory tract infections. · lower respiratory tract infections. · skin and soft tissue infections.
klacid susp.125 125 mg/5ml
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 125 mg/5ml - 125 mg/5ml
klacid susp.125 125 mg/5ml
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 125 mg/5ml - 125 mg/5ml